{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:57:13Z","timestamp":1785002233656,"version":"3.55.0"},"reference-count":39,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Beta-lactam allergy labels (BLALs), especially penicillin allergy labels, are frequently recorded in hospitalized patients and are associated with increased use of broad-spectrum and second-line antibiotics. Most BLALs are incorrect, but current allergy workups require invasive testing and specialized resources. We recently developed a strictly noninvasive, electronic patient record\u2013embedded clinical decision support tool, the Allergy Fact Checker (AFC), which proactively identifies potentially incorrect BLALs by detecting uneventful re-exposures to the culprit or other beta-lactams since introduction of the BLAL.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to evaluate the clinical, antimicrobial, and economic impact of the AFC in hospitalized adults with BLALs compared to the standard of care (no AFC).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We are conducting a multicenter, open-label, crossover cluster-controlled study in 9 hospitals in Flanders, Belgium. All hospitalized adults with a BLAL are eligible, excluding patients in palliative care, discharged within 24 hours, or previously enrolled. Each hospital will alternate between intervention (use of the AFC) and control (standard practice) phases, separated by washout periods. The primary endpoint is cumulative guideline-concordant prescribing of first-line and\/or narrow-spectrum beta-lactams following local antibiotic treatment guidelines, across predefined care windows up to day 100, expressed as a weighted per-patient proportion. Secondary endpoints include delabeling or refinement rate, beta-lactam tolerance, antibiotic switching, hospital length of stay, in-hospital and 3-month mortality, intensive care unit admission, readmission, multidrug-resistant organism colonization or infection, and costs. Based on prior data, we calculated that a total of 3285 participants are required to achieve 80% power to detect superiority of the intervention (4.6% vs 9.9% appropriate prescribing). Recruitment started in March 2025 and is ongoing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The primary outcome will be analyzed using hierarchical mixed-effect models accounting for hospital-level clustering and period effects. Data collection will continue until 200 days after the last patient is discharged. This trial is expected to conclude in 2026. Ethical approval was obtained from the institutional review board in November 2024. Recruitment started in March 2025 and is ongoing. As of manuscript submission, more than 3000 participants have been enrolled across the participating hospitals. According to the prespecified protocol, an interim assessment of nuisance parameters will be performed in the following month to evaluate the initial design assumptions. Data collection is expected to continue until the end of 2026. The main study results are anticipated to be reported in 2027.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This is the first multicenter European study evaluating a strictly noninvasive BLAL delabeling approach. If successful, this AFC tool could improve antimicrobial stewardship, reduce costs, and provide a scalable model for centralized allergy label management.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/86056","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:42:13Z","timestamp":1774633333000},"page":"e86056-e86056","source":"Crossref","is-referenced-by-count":1,"title":["Impact Assessment of the Allergy Fact Checker, a Clinical Decision Support Tool for Noninvasive Beta-Lactam Antibiotic Allergy Label Delabeling: Protocol for a Multicenter Crossover Cluster-Controlled Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-3104","authenticated-orcid":false,"given":"Liesbeth","family":"Gilissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1475-6178","authenticated-orcid":false,"given":"Greet","family":"Van De Sijpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-0676","authenticated-orcid":false,"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4261-6220","authenticated-orcid":false,"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"10167","key":"R1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","journal-title":"Lancet"},{"issue":"3","key":"R2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bcp.13830","article-title":"Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labelling","volume":"85","author":"Moran","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"R3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","journal-title":"Am J Med"},{"issue":"9","key":"R4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","journal-title":"Allergy"},{"issue":"8","key":"R5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1592\/phco.31.8.742","article-title":"Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients","volume":"31","author":"Charneski","journal-title":"Pharmacotherapy"},{"issue":"4","key":"R6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.anai.2017.07.009","article-title":"Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression","volume":"119","author":"Sousa-Pinto","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"R7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jaip.2016.03.009","article-title":"The high impact of penicillin allergy registration in hospitalized patients","volume":"4","author":"van Dijk","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"R8","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.jaip.2021.01.047","article-title":"Prevalence of antibiotic allergy labels in a tertiary referral center in Belgium","volume":"9","author":"Gilissen","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/cid\/ciaa653","article-title":"The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study","volume":"73","author":"Chua","journal-title":"Clin Infect Dis"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaip.2017.04.045","article-title":"Designing predictive models for beta-lactam allergy using the drug allergy and hypersensitivity database","volume":"6","author":"Chiriac","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"R11","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/all.14292","article-title":"Prevalence of self-reported and confirmed penicillin allergy in a Belgian outpatient population","volume":"75","author":"Van Gasse","journal-title":"Allergy"},{"issue":"11","key":"R12","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.clinthera.2017.09.012","article-title":"Impact of penicillin allergy on time to first dose of antimicrobial therapy and clinical outcomes","volume":"39","author":"Conway","journal-title":"Clin Ther"},{"issue":"6","key":"R13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ajic.2019.09.021","article-title":"Is there a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) colonization in patients with antibiotic allergy labels?","volume":"48","author":"Lam","journal-title":"Am J Infect Control"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.1269","article-title":"Drug resistant infections with methicillin-resistant Staphylococcus aureus, clostridium difficile, and vancomycin resistant Enterococcus are associated with a higher prevalence of penicillin allergy","volume":"131","author":"Reddy","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"R16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s11606-019-04991-y","article-title":"Recorded penicillin allergy and risk of mortality: a population-based matched cohort study","volume":"34","author":"Blumenthal","journal-title":"J Gen Intern Med"},{"issue":"1","key":"R17","first-page":"29","volume":"71","author":"Wu","journal-title":"Can J Hosp Pharm"},{"issue":"3","key":"R18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaip.2013.01.006","article-title":"Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital","volume":"1","author":"Picard","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2222.2003.01638.x","article-title":"The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital","volume":"33","author":"Sade","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jaip.2017.12.033","article-title":"The cost of self-reported penicillin allergy: a systematic review","volume":"6","author":"Mattingly","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.70166","article-title":"Clinical outcome associated with beta\u2010lactam allergy labels in hospitalized patients in Belgium","author":"Gilissen","journal-title":"Clinical and Translational Allergy (forthcoming)"},{"issue":"3","key":"R22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing inpatient beta-lactam allergies: a multihospital implementation","volume":"5","author":"Blumenthal","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"R23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","journal-title":"JAMA Intern Med"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper","volume":"75","author":"Romano","journal-title":"Allergy"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.anai.2019.04.009","article-title":"Acute care beta-lactam allergy pathways: approaches and outcomes","volume":"123","author":"Wolfson","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"R27","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dky575","article-title":"Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital","volume":"74","author":"du Plessis","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13058","article-title":"Antibiotic allergy labels-the impact of taking a clinical history","volume":"72","author":"Torda","journal-title":"Int J Clin Pract"},{"issue":"6","key":"R29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/jac\/dkz082","article-title":"Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention","volume":"74","author":"Devchand","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"R30","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1111\/all.15453","article-title":"Non-invasive delabeling and refining of beta-lactam allergy labels in inpatients to optimize antimicrobial stewardship","volume":"77","author":"Van De Sijpe","journal-title":"Allergy"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02030-1","article-title":"Evaluation of the Allergy Fact Checker, a clinical decision support system for non-invasive beta-lactam delabeling: a mixed-methods study","volume":"8","author":"Van De Sijpe","journal-title":"NPJ Digit Med"},{"key":"R32","unstructured":"Wet inzake experimenten op de menselijke persoon (law on experiments on the human person). May 7, 2004."},{"key":"R33","unstructured":"STAAL studie [article in dutch]. KU Leuven. URL: https:\/\/gbiomed.kuleuven.be\/english\/research\/50000698\/50000631\/staal-studie\/staalstudie [Accessed 07-03-2026]"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Catteau. Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey sciensano.be. SHEA Spring; 2024. URL: https:\/\/www.sciensano.be\/sites\/default\/files\/shea_poster_pps_lc.pdf [Accessed 07-03-2026]","DOI":"10.1017\/ash.2024.328"},{"issue":"2","key":"R35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.recesp.2015.04.018","article-title":"Variabilidad interhospitalaria en la prescripci\u00f3n tras un s\u00edndrome coronario agudo: hallazgos del estudio ACDC","volume":"69","author":"Ferreira-Gonz\u00e1lez","journal-title":"Rev Esp Cardiol"},{"issue":"638","key":"R36","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.3399\/bjgp15X686497","article-title":"Clinical predictors of antibiotic prescribing for acutely ill children in primary care: an observational study","volume":"65","author":"O\u2019Brien","journal-title":"Br J Gen Pract"},{"issue":"1","key":"R37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13756-019-0663-7","article-title":"Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017","volume":"9","author":"Vandael","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"R38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/ije\/dyz237","article-title":"A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator","volume":"49","author":"Hemming","journal-title":"Int J Epidemiol"},{"key":"R39","unstructured":"The Shiny CRT Calculator: Power and Sample size for Cluster Randomised Trials. URL: https:\/\/clusterrcts.shinyapps.io\/rshinyapp\/ [Accessed 07-03-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e86056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:14:05Z","timestamp":1782839645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e86056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2196\/86056","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"v15i10167e86056"}}